PLSE (Pulse Biosciences) Revenue: $0.75 Mil (TTM As of Mar. 2026)


PLSE Pulse Biosciences Inc PLSE
31 GF Score
Price $29.23
! 3 Warning Signs
View Full Analysis

What is Pulse Biosciences Revenue?

Pulse Biosciences PLSE +3.27% 31 Revenue is $0.75 Mil as of Mar. 2026. GuruFocus rates PLSE with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

Pulse Biosciences's revenue for the three months ended in Mar. 2026 was $0.40 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $0.75 Mil. Pulse Biosciences's Revenue per Share for the three months ended in Mar. 2026 was $0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.01.

Warning Sign:

Pulse Biosciences Inc revenue per share has been in decline over the past 3 years.

During the past 3 years, the average Revenue per Share Growth Rate was -37.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 12 years, Pulse Biosciences's highest 3-Year average Revenue per Share Growth Rate was -37.00% per year. The lowest was -37.00% per year. And the median was -37.00% per year.


Pulse Biosciences  (NAS:PLSE) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Pulse Biosciences Revenue Related Terms


Pulse Biosciences Revenue Historical Data

* Premium members only.

The historical data trend for Pulse Biosciences's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulse Biosciences Revenue Chart

Pulse Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.42 0.70 0.00 0.00 0.35

Pulse Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.09 0.26 0.40

PLSE vs LMAT, XRAY, KMTS: Revenue Comparison

For the Medical Instruments & Supplies subindustry, Pulse Biosciences's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulse Biosciences Revenue vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's Revenue distribution charts can be found below:

* The bar in red indicates where Pulse Biosciences's Revenue falls into.


PLSE
31GF Score
Pulse Biosciences Inc PLSE
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pulse Biosciences Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $0.75 Mil mean?
Pulse Biosciences (PLSE) has a Revenue of $0.75 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Pulse Biosciences and its competitors.
Is Pulse Biosciences' Revenue too high?
Pulse Biosciences' current Revenue is $0.75 Mil. Overall, Pulse Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' Revenue compare to LMAT and XRAY?
Pulse Biosciences' Revenue of $0.75 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Pulse Biosciences and its competitors. Pulse Biosciences's current Revenue is $0.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (PLSE) has a current Revenue of $0.75 Mil. The current Revenue is $0.75 Mil. Pulse Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Pulse Biosciences (PLSE), the current Revenue is $0.75 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pulse Biosciences Business Description

Other Exchanges 6L8:Germany
Address 601 Brickell Key Drive, Suite 1080, Miami, FL, USA, 33131
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
31GF Score

Get the complete analysis for PLSE

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.23
Price